Category Archives: Mesenchymal Stem Cells

Home > Biotherapy > Cell Culture > Mesenchymal stem cells Discover the MC3 system video by clicking on the picture below Connections: 1 MPC connector 2 needleless access ports 1 spike Download brochure for product description Download brochure for product description Download brochure for product description Connection: 1 MPC connector 1 needleless access port 1 spike Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description Download brochure for product description View original post here: Mesenchymal stem cells | Macopharma … Continue reading →

Stems Cells and relatedresearch reagents are building blocks from catalyzing important discoveries.We invest in providing our customers the latest stem cellresearch tools and methods. Weoffer: hNSCs + Culturing Media,hMSCs + Media, Tox/QC SC Assays, 3-D CulturingTools, Cryo-preservatives, Growth Factor Proteinsand Markers.They are research proven (many are referenced in publications) and ready to use. Images: Immunostaining ofhNP1 TMHuman Neural Progenitors. The culture was highly homogenous with neural rosettes. (A) Neural rosettes (white arrows, bright field)from WA09 cells. A similar result also obtained with BG02 cell line. (B) Shown here, a neural rosette stained with Nestin (NES) (green) antibody. Propagated Neural progenitors showed expression of marker genes, NES (C) and Musashi-1(D) but not SOX2 (E). Further differentiation produced neurons (Tuj 1-Neuron-specific class III beta-tubulin) (F), astrocytes (GFAP) (G) and oligodendrocytes (myelin basic protein)(H) (lower panel). DAPI (blue) was used for staining the nuclei (scale bar for (A) through (E) is 100 mm and for the remaining figures 10 mm).Differentiation 76 (5) , 454464 doi:10.1111/j.1432-0436.2007.00256.x. Dilutions: (B&C)NES (1:100), (D)MSI1 (1:100, ), (F)Tuj1 (1:500)... Link: Research Ready Stem Cell Research Reagents … Continue reading →

Stem Cell Research & Therapy20156:260 DOI: 10.1186/s13287-015-0263-2 Reppel et al.2015 Received: 12May2015 Accepted: 8December2015 Published: 30December2015 Due to their intrinsic properties, stem cells are promising tools for new developments in tissue engineering and particularly for cartilage tissue regeneration. Although mesenchymal stromal/stem cells from bone marrow (BM-MSC) have long been the most used stem cell source in cartilage tissue engineering, they have certain limits. Thanks to their properties such as low immunogenicity and particularly chondrogenic differentiation potential, mesenchymal stromal/stem cells from Whartons jelly (WJ-MSC) promise to be an interesting source of MSC for cartilage tissue engineering. In this study, we propose to evaluate chondrogenic potential of WJ-MSC embedded in alginate/hyaluronic acid hydrogel over 28days. Hydrogels were constructed by the original spraying method. Our main objective was to evaluate chondrogenic differentiation of WJ-MSC on three-dimensional scaffolds, without adding growth factors, at transcript and protein levels. We compared the results to those obtained from standard BM-MSC. After 3days of culture, WJ-MSC seemed to be adapted to their new three-dimensional environment without any detectable damage. From day 14 and up to 28days, the proportion of WJ-MSC CD73+, CD90+, CD105+ and CD166+ decreased significantly compared to monolayer marker expression. Moreover, WJ-MSC and BM-MSC showed different … Continue reading →

BASIC RESEARCH ON MESENCHYMAL STEM CELL BIOLOGY RELEASE DATE: March 6, 2002 RFA: HL-02-018 National Heart, Lung and Blood Institute (NHLBI) (http://www.nhlbi.nih.gov)National Institute on Aging (NIA) (http://www.nia.nih.gov) LETTER OF INTENT RECEIPT DATE: May 15, 2002 APPLICATION RECEIPT DATE: June 20, 2002 THIS RFA CONTAINS THE FOLLOWING INFORMATIONo Purpose of this RFAo Research Objectiveso Mechanism of Support o Funds Availableo Eligible Institutionso Individuals Eligible to Become Principal Investigatorso Special Requirementso Where to Send Inquirieso Letter of Intento Submitting an Applicationo Peer Review Processo Review Criteriao Receipt and Review Scheduleo Award Criteriao Required Federal Citations:PURPOSE OF THIS RFA Preclinical studies suggest mesenchymal stem cells facilitate hematopoietic stem cell transplantation while decreasing immune rejection of allogeneic transplants. In addition, mesenchymal stem cells have been demonstrated to differentiate into a variety of non-hematopoietic tissues including bone, cartilage, tendon, fat, skeletal and cardiac muscle, and early progenitors of neural cells. The National Heart, Lung and Blood Institute and National Institute on Aging invite applications on basic research on mesenchymal stem cell biology that will provide the basis for clinical application to hematopoietic and non-hematopoietic stem cell transplantation. RESEARCH OBJECTIVESBackgroundMesenchymal stem cells are pluripotent progenitor cells located in bone marrow that can differentiate into a variety … Continue reading →

Stem Cell Research & Therapy20167:16 DOI: 10.1186/s13287-016-0283-6 Chen and Hou.2016 Published: 7February2016 Kidney transplantation is the best treatment for end-stage renal disease, but its implementation is limited by organ shortage and immune rejection. Side effects of current immunosuppressive drugs, such as nephrotoxicity, opportunistic infection, and tumorigenic potential, influence long-term graft outcomes. In recent years, continued research and subsequent discoveries concerning the properties and potential utilization of mesenchymal stem cells (MSCs) have aroused considerable interest and expectations. Biological characteristics of MSCs, including multi-lineage differentiation, homing potential, paracrine effect and immunomodulation, have opened new horizons for applications in kidney transplantation. However, many studies have shown that the biological activity of MSCs depends on internal inflammatory conditions, and the safety and efficacy of the clinical application of MSCs remain controversial. This review summarizes the findings of a large number of studies and aims to provide an objective viewpoint based on a comprehensive analysis of the presently established benefits and obstacles of implementing MSC-based therapy in kidney transplantation, and to promote its clinical translation. The number of patients with chronic kidney disease and end-stage renal disease (ESRD) increases each year. Kidney transplantation is an effective long-term means of treatment for ESRD, but is closely … Continue reading →

Adv Drug Deliv Rev. Author manuscript; available in PMC 2011 Sep 30. Published in final edited form as: PMCID: PMC2991625 NIHMSID: NIHMS234731 Department of Animal Biotechnology, University of Nevada, Reno, NV Mesenchymal stem cells (MSCs) possess a set of several fairly unique properties which make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles for gene and drug delivery. These include: 1) relative ease of isolation; 2) the ability to differentiate into a wide variety of seemingly functional cell types of both mesenchymal and non-mesenchymal origin; 3) the ability to be extensively expanded in culture without a loss of differentiative capacity; 4) they are not only hypoimmunogenic, but they produce immunosuppression upon transplantation; 5) their pronounced anti-inflammatory properties; and 6) their ability to home to damaged tissues, tumors, and metastases following in vivo administration. In this review, we summarize the latest research in the use of mesenchymal stem cells in regenerative medicine, as immunomodulatory/anti-inflammatory agents, and as vehicles for transferring both therapeutic genes in genetic disease and genes designed to destroy malignant cells. In pioneering studies [1, 2] performed over 30 years ago, Friedenstein demonstrated that fibroblastoid cells obtained from the bone marrow were capable of transferring the … Continue reading →

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com. SOURCE ReportBuyer LONDON, Feb. 11, 2016 /PRNewswire/ -- Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and a limited range of other cell types MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases They are advantageous over other stem cells types for a variety of reasons They avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation MSCs also being explored for use in 3D printing applications, because of their unique capacity to form structural tissues You are here: Home / Stem Cell Market Research / Mesenchymal Stem Cells Advances & Applications Mesenchymal Stem Cells Advances & Applications Mesenchymal Stem Cells Advances & Applications Category: Stem Cell Market Research Tags: … Continue reading →

LONDON, Feb. 11, 2016 /PRNewswire/ -- Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and a limited range of other cell types MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases They are advantageous over other stem cells types for a variety of reasons They avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation MSCs also being explored for use in 3D printing applications, because of their unique capacity to form structural tissues You are here: Home / Stem Cell Market Research / Mesenchymal Stem Cells Advances & Applications Mesenchymal Stem Cells Advances & Applications Mesenchymal Stem Cells Advances & Applications Category: Stem Cell Market Research Tags: adipose-tissue, market research, mesenchymal stem cells, stem cells, strategy, trends Description 186 Shares1725 Product Description Global Strategic Report 250 Pages; November 2015 Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including … Continue reading →

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease of unknown etiology, characterized by excessive scarring (fibrosis) of the lung due to an increase in number and uncontrolled activity of cells called fibroblasts. Destruction of normal lung structure usually leads to death from lung failure within five years of diagnosis. Currently available therapeutic approaches offer little clinical benefit. It has recently been suggested that injury to the lining cells of the lung (epithelial cells) may contribute by releasing substances (mediators) that stimulate fibroblasts to increase in number leading to scarring. In turn, fibroblasts may release mediators that can lead to epithelial cell death preventing normal repair. Studies in animals have demonstrated that administration of a particular type of stem cell derived from adult bone marrow known as a mesenchymal stem cell (MSC) can improve outcome from a number of types of lung injury and prevent subsequent scarring. The mechanisms responsible for the helpful effects of MSC are not well understood and may include changes in the immune system and secretion of mediators that prevent epithelial cells from dying. This may tip the balance in favor of repair of lung damage and resolution of the injury. Experimental studies as well as … Continue reading →

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com. SOURCE ReportBuyer LONDON, Feb. 11, 2016 /PRNewswire/ -- Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and a limited range of other cell types MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases They are advantageous over other stem cells types for a variety of reasons They avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation MSCs also being explored for use in 3D printing applications, because of their unique capacity to form structural tissues You are here: Home / Stem Cell Market Research / Mesenchymal Stem Cells Advances & Applications Mesenchymal Stem Cells Advances & Applications Mesenchymal Stem Cells Advances & Applications Category: Stem Cell Market Research Tags: … Continue reading →